[1] Soleimani M, Khorsandi L, Atashi A,et al.Chondrogenic Differentiation of Human Umbilical Cord Blood-Derived Unrestricted Somatic Stem Cells on A 3D Beta-Tricalcium Phosphate-Alginate-Gelatin Scaffold.Cell J. 2014;16(1): 43-52.
[2] Seo KW, Sohn SY, Bhang DH,et al.Therapeutic effects of hepatocyte growth factor-overexpressing human umbilical cord blood-derived mesenchymal stem cells on liver fibrosis in rats.Cell Biol Int. 2014;38(1):106-116.
[3] Pham PV, Vu NB, Pham VM,et al.Good manufacturing practice-compliant isolation and culture of human umbilical cord blood-derived mesenchymal stem cells.J Transl Med. 2014;12:56.
[4] Liu Y, Zhang B, Zhang J,et al.CAPE promotes the expansion of human umbilical cord blood-derived hematopoietic stem and progenitor cells in vitro.Sci China Life Sci. 2014;57(2): 188-194.
[5] Liu SS, Zhang C, Zhang X,et al.Human umbilical cord blood-derived stromal cells: A new source of stromal cells in hematopoietic stem cell transplantation.Crit Rev Oncol Hematol. 2014;90(2):93-98.
[6] Mareschi K, Ferrero I, Rustichelli D,et al.Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow.J Cell Biochem. 2006;97(4):744-754.
[7] Secco M, Zucconi E, Vieira NM,et al.Multipotent stem cells from umbilical cord: cord is richer than blood!Stem Cells. 2008; 26(1):146-150.
[8] Li T, Ma Q, Ning M,et al.Cotransplantation of human umbilical cord-derived mesenchymal stem cells and umbilical cord blood-derived CD34? cells in a rabbit model of myocardial infarction.Mol Cell Biochem. 2014;387(1-2):91-100.
[9] Lee M, Jeong SY, Ha J,et al.Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo.Biochem Biophys Res Commun. 2014;446(4):983-989.
[10] Lee JH, Hah YS, Cho HY,et al.Human umbilical cord blood-derived CD34-positive endothelial progenitor cells stimulate osteoblastic differentiation of cultured human periosteal-derived osteoblasts.Tissue Eng Part A. 2014;20 (5-6): 940-953.
[11] Kanji S, Das M, Aggarwal R, et al.Nanofiber-expanded human umbilical cord blood-derived CD34(+) cell therapy accelerates cutaneous wound closure in NOD/SCID mice.J Cell Mol Med. 2014;18(4):685-697.
[12] Kanji S, Das M, Aggarwal R,et al.Nanofiber-expanded human umbilical cord blood-derived CD34+ cell therapy accelerates murine cutaneous wound closure by attenuating pro-inflammatory factors and secreting IL-10.Stem Cell Res. 2014;12(1):275-288.
[13] Jing W, Chen Y, Lu L,et al.Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Producing IL15 Eradicate Established Pancreatic Tumor in Syngeneic Mice.Mol Cancer Ther. 2014;13(8):2127-2137.
[14] Gang EJ, Jeong JA, Hong SH,et al.Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood.Stem Cells. 2004;22(4):617-624.
[15] Lee DH, Ahn Y, Kim SU,et al.Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells.Clin Cancer Res. 2009;15(15):4925-4934.
[16] Le Blanc K, Tammik C, Rosendahl K, et al.HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells.Exp Hematol. 2003;31(10):890-896.
[17] Wang M, Yang Y, Yang D, et al.The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro.Immunology. 2009;126(2):220-232.
[18] Hao L, Zhang C, Chen XH,et al.Human umbilical cord blood-derived stromal cells suppress xenogeneic immune cell response in vitro.Croat Med J. 2009;50(4):351-360.
[19] Di Nicola M, Carlo-Stella C, Magni M,et al.Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.Blood. 2002;99(10):3838-3843.
[20] Ren G, Su J, Zhang L,et al.Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.Stem Cells. 2009;27(8):1954-1962.
[21] Goldring MB, Marcu KB.Cartilage homeostasis in health and rheumatic diseases.Arthritis Res Ther. 2009;11(3):224.
[22] Rico MC, Castaneda JL, Manns JM,et al.Amelioration of inflammation, angiogenesis and CTGF expression in an arthritis model by a TSP1-derived peptide treatment.J Cell Physiol. 2007;211(2):504-512.
[23] Mao F, Xu WR, Qian H,et al.Immunosuppressive effects of mesenchymal stem cells in collagen-induced mouse arthritis. Inflamm Res. 2010;59(3):219-225.
[24] Mobasheri A, Csaki C, Clutterbuck AL,et al.Mesenchymal stem cells in connective tissue engineering and regenerative medicine: applications in cartilage repair and osteoarthritis therapy.Histol Histopathol. 2009;24(3):347-366.
[25] Nakamizo A, Marini F, Amano T, et al.Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.Cancer Res. 2005;65(8):3307-3318.
[26] Kim SM, Lim JY, Park SI,et al.Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.Cancer Res. 2008;68(23):9614-9623.
[27] Kim DS, Kim JH, Lee JK,et al.Overexpression of CXC chemokine receptors is required for the superior glioma-tracking property of umbilical cord blood-derived mesenchymal stem cells.Stem Cells Dev. 2009;18(3): 511-519.
[28] Cai H, Zhang Z, Yang GY.Preconditioned stem cells: a promising strategy for cell-based ischemic stroke therapy.Curr Drug Targets. 2014;15(8):771-779.
[29] Sanberg PR, Willing AE, Garbuzova-Davis S, et al.Umbilical cord blood-derived stem cells and brain repair.Ann N Y Acad Sci. 2005;1049:67-83.
[30] Chung DJ, Choi CB, Lee SH,et al.Intraarterially delivered human umbilical cord blood-derived mesenchymal stem cells in canine cerebral ischemia.J Neurosci Res. 2009;87(16): 3554-3567.
[31] Jeong CH, Park SI, Kim SM, et al. Human umbilical cord blood-derived mesencymal stem cell therapy for stroke in rat. Tissue Engineering and Regenerative Medicine. 2006;3: 445-450.
[32] Moodley Y, Atienza D, Manuelpillai U,et al.Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury.Am J Pathol. 2009;175(1): 303-313.
[33] Chang YS, Oh W, Choi SJ, et al.Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats.Cell Transplant. 2009;18(8):869-886.
[34] Yan Y, Xu W, Qian H, et al.Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo.Liver Int. 2009;29(3):356-365.
[35] 武丽萍,蔡力,陶剑虹,等.不同月龄人脐带间充质干细胞移植梗死心肌的血运重建[J].中国组织工程研究,2013,17(49):8520- 8526. |